Fc receptor blocking antibodies after active immunization for the treatment of recurrent spontaneous abortion.
In a prospective study 140 couples who had at least three spontaneous abortions (RSA) were studied for the presence of Fc receptor blocking antibodies detected by the erythrocyte antibody rosette inhibition (EAI) assay, for anti-paternal cytotoxic antibodies (APCA), and for mixed lymphocyte culture inhibiting (MLCI) antibodies before and after active immunization with paternal lymphocytes. The comparative analysis revealed the EAI assay to possess a higher sensitivity than the APCA and/or MLCI tests in monitoring the specific immune response after active immunization. The success of pregnancy in EAI positive post-immunization patients was not influenced by the presence or absence of APCA or MLCI. In the light of a successful pregnancy outcome of 85.7% (n = 37) in this study we conclude that the monitoring of Fc receptor blocking antibodies is useful in active immunization protocols for RSA patients.
Kuhn
U
U
Institut für Immungenetik, Universitätsklinikum Essen, Germany.
Blasczyk
R
R
Hojnacki
B
B
Vögeler
U
U
Luboldt
W
W
Passarge
E
E
Fischer
W M
WM
Grosse-Wilde
H
H
D000026:Abortion, Habitual / Q000276:immunology* / Q000628:therapy; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007959:Lymphocyte Culture Test, Mixed; D009000:Monocytes / Q000276:immunology; D011247:Pregnancy / Q000276:immunology*; D011446:Prospective Studies; D011961:Receptors, Fc / Q000276:immunology*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology
D011961:Receptors, Fc